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The Saccharomyces cerevisiae leucine-inserting amber suppressor tRNA gene SUP53 (a tRNA}"u allele) was 
used to investigate the relationship between precursor tRNA structure and mature tRNA function. This gene 
encodes a pre-tRNA which contains a 32-base intron. The mature tRNAsuPsJ contains a 5-methylcytosine 
modification of the anticodon wobble base. Mutations were made in the SUP53 intron. These mutant genes 
were transcribed in an S. cerevisiae nuclear extract preparation. In this extract, primary tRNA gene transcripts 
are end-processed and base modified after addition of cofactors. The base modifications made in vitro were 
examined, and the mutant pre-tRNAs were analyzed for their ability to serve as substrates for partially purified 
S. cerevisiae tRNA endonuclease and ligase. Finally, the suppressor function of these mutant tRNA genes was 
assayed after their integration into the S. cerevisiae genome. Mutant analysis showed that the totally intact 
precursor tRNA, rather than any specific sequence or structure of the intron, was necessary for efficient 
nonsense suppression by tRNAsuPsJ. Less efficient suppressor activity correlated with the absence of the 
5-methylcytosine modification. Most of the intron-altered precursor tRNAs were successfully spliced in vitro, 
indicating that modifications are not critical for recognition by the tRNA endonuclease and ligase. 
Intervening sequences (IVS), or introns, have been found 
in the genes which encode the major classes of eucaryotic 
RNA, both nuclear and organellar. Recently, the mecha-
nisms by which introns are removed from the primary RNA 
transcript have been the focus of intense investigation (re-
viewed in references 7, 14, and 51). However, relatively few 
experiments have elucidated a biological function for an IVS 
separate from the role of intron sequence or structure in the 
splicing process. 
Saccharomyces cerevisiae affords an ideal system for 
investigating intron function. A number of yeast nuclear 
mRNA and tRNA genes containing introns have been 
cloned. These genes can be mutated in vitro and the mutant 
phenotype assayed by introducing the mutated genes into 
yeast cells by chromosomal integration. Using these meth-
ods, Ng et al. (40) showed that precise removal of the S. 
cerevisiae actin gene intron did not affect the production of 
actin mRNA or actin protein in vivo. Cells containing only 
the intron-deleted actin gene exhibit a normal growth rate 
and normal meiotic products upon sporulation. 
In contrast, Johnson and Abelson (22) found that precise 
removal of the intron from an S. cerevisiae suppressor tRNA 
gene has profound effects on the phenotype of the mature 
suppressor tRNA product. Comparing strains containing the 
tyrosine-inserting ocher suppressor tRNAsur6 and its intron-
deleted counterpart SUP6!J.32, they found that SUP6!J.32 
was inefficient in suppressing ocher nonsense mutations. 
When in vivo-labeled tRNA Tyr from the two strains was 
examined, SUP6-specific RNA from the deletion strain 
lacked a pseudouridine (\fl) base modification normally found 
on the central uridine of the UUA anticodon. These data 
suggest that the IVS-containing precursor, by virtue of either 
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its total structure or some specific feature of the IVS itself, is 
recognized as the appropriate substrate for this pseudo-
uridylation enzyme. 
In this study we are directly examining the role of intron 
sequence and structure on precursor tRNA processing and 
mature tRNA function. The S. cerevisiae tRNA gene SUP53 
(a tRNAreu allele) encodes a leucine-inserting, amber sup-
pressor tRNA. Pre-tRNAsursJ contains a 32-base intron. 
Intron-mutated genes were constructed and transcribed in 
vitro. These transcripts were analyzed for base modifica-
tions and for their ability to be spliced in vitro. Finally, the 
in vitro phenotype of each mutant was correlated with its in 
vivo suppressor function after integration into the S. cerevi-
siae genome. 
The results show that the entire intron, or the total 
precursor tRNA structure, is required for efficient suppres-
sor function of the resultant mature tRNA. The reduced 
suppressor phenotype is correlated with lack of a 5-
methylcytosine modification of the anticodon wobble base. 
However, undermodification of a precursor tRNA per se has 
no effect on its ability to serve as substrate for the S. 
cerevisiae endonuclease and ligase in vivo. In fact, most 
alterations in the intron, unless they perturb the overall 
structure of the precursor tRNA, do not impair splicing 
enzyme function. 
MATERIALS AND METHODS 
Strains, plasmids, and media. The sequence of S. cerevi-
siae SUP53 precursor and mature tRNAs is shown in Fig. 1. 
SUP53, an amber suppressor allele oftRNAreu, is located on 
the left arm of S. cerevisiae chromosome III, closely linked 
to the LEU2 marker (1, 10, 31). The SUP53 gene was cloned 
by gene replacement into the yeast integrative plasmid 
YlpLEU2 (YipLEU2SUP53, kindly provided by A. New-
man [39]). To assess their in vivo function, SUP53 and 
mutant genes cloned in YipLEU2 were introduced into S. 
cerevisiae SL183-21C [a met8-l(Am) tyr7-l(Am) trpl-l(Am) 
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FIG. 1. Structure of precursor and mature species of tRNAsuPJJ. (A) Structure of pre-tRNAsuPJJ. The 32-base intron is delineated by the 
large arrows. The Hpal restriction enzyme site, located within the intron of the SUP53 gene, is shown. Numbering of the mature domain is 
by the convention established for tRNAPh•. (B) Cloverleaf structure ofthe mature tRNAsuPJJ, including nucleoside modifications. The Alul 
restriction enzyme site created in the SUP53~IVS mutant gene is shown. This site precisely divides the SUP53~IVS gene into 5'-half and 
3'-half genes. Abbreviations for nucleoside modifications: Me, methyl; 2'-0-Me, 2'-0-methyl; diMe, dimethyl; lj!, pseudouridine; and T, 
ribothymidine. 
ade3-26(Am) ilvl-l(Am) leu2-1(0c) lys2-1(0c) canRJ-
132(Am), kindly provided by S. Liebman]. 
Yeast cultures were routinely grown in YPD medium. 
Leu+ yeast transformants were assayed on drop-out plates 
of synthetic complete medium minus leucine. Suppressor 
tRNA function of Leu+ transformants was assayed on 
drop-out plates of synthetic complete medium minus 
tryptophan. All yeast media were made by the formulations 
of Sherman et al. (52). 
A 772-base-pair (bp) Alul fragment of YlpLEU2SUP53, 
containing the entire tRNA gene and the 5' terminus of the 
LEU2 gene, was subcloned into the Smal site of M13mp8, 
kindly provided by A. Newman (39) (Fig. 2A). M13SUP53 
(Fig. 2B) and the in vitro mutagenesis-derived M13SUP53 
.:1IVS (Fig. 2C) were used in additional mutant constructions 
described below. Recombinant molecules in which the vec-
tor sequences were provided by Ml3 were transformed into 
Escherichia coli JMlOl [.:1(/ac-pro) supE thi F' traD36 proAB 
lacqZ.:1Ml5; J. Messing, personal communication]. 
Preparatory to introducing SUP53 or its mutant deriva-
tives into yeast cells, the small Avai-BstEII fragment from 
M13 clones was subcloned into YlpLEU2 linearized with 
A val and BstEII (Fig. 2). The resident tRNAteu ofYipLEU2 
was replaced with the appropriate S UP53 allele, and the 
LEU2 gene was reconstructed. YlpLEU2, YlpLEU2 
SUP53, and the mutant derivatives were transformed into E. 
coli HBlOl (F- hsdS20 recAJ3 ara-14 proA2 lac Y1 galK2 
rpsL20 xyl-5 mtl-1 supE44 A-) (5). 
Bacterial cultures were grown in YT medium for M13 
phage or YT medium plus ampicillin (Polycillin; 40 to 60 
J.Lg/ml) for YlpLEU2-derived plasmids. All bacterial media 
were made as described by Miller (36). 
All restriction endonucleases Were obtained from com-
mercial sources (Bethesda Research Laboratories, Gaith-
ersburg, Md.; New England Biolabs, Beverly, Mass.; 
Boehringer Mannheim, Indianapolis, Ind.) and used under 
the reaction conditions recommended by the manufacturers. 
Mutant construction. The SUP 53 mutants investigated in 
this study are shown in Fig. 3. These mutants were made 
either by oligonucleotide-directed mutagenesis, by the liga-
tion of half-tRNA genes, or by cloning of complementary 
oligonucleotides. All mutants were initially constructed in 
M13mp8 or mplO and subsequently transferred into 
YlpLEU2 (Fig. 2). 
The .:1IVS, anticodon base-pairing (ACBP), and insert 
(INS) mutants were constructed by oligonucleotide-directed 
mutagenesis as previously described (39) . .:13'1VS and 
.:15'IVS were made by ligating half-tRNA genes generated by 
cutting SUP53 at the unique Hpal site (Fig. lA and 2B) and 
SUP53.:1IVS by cutting at a unique intragenic Alul site (Fig. 
lB and 2C). The SUP53 clone was triply digested with 
EcoRI, BamHI, and Hpal, and SUP53.:1IVS was similarly 
cut with EcoRI, BamHI, and Alul. These digests were 
resolved on 6% acrylamide gels. The appropriate bands were 
excised from the gel and crush-eluted overnight at 37°C. The 
isolated EcoRI-Hpal and Alui-BamHI or EcoRI-Alul and 
Hpai-BamHI fragments were ligated into Ml3mpl0 linear-
ized with EcoRl and BamHI, creating .:13'IVS and .:15'1VS, 
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FIG. 2. General strategy for construction of SUP53 mutants and their introduction into the S. cerevisiae integration vector YlpLEU2. 
YlpLEU2SUP53 (A) was constructed by replacement of the tRNA~u gene normally present on the yeast integration vector YlpLEU2 with 
its amber suppressor allele SUP53. M13SUP53 (B) was constructed by cloning the 772-bp Alul fragment of YlpLEU2SUP53 into the unique 
Smal site of M13mp8. M13SUP534IVS (C) was made by oligonucleotide-directed deletion of the 32-bp intron of SUP53, as described in 
Materials and Methods. The SUP534IVS and additional mutant genes were introduced into the YlpLEU2 vector by isolation of the -1,100-bp 
Aval-BstEll fragment of ~13SUP534IVS, followed by its ligation into Avai-BstEII-Iinearized YlpLEU2. M13SUP53 and M13SUP534IVS 
were used for the construction of additional mutants in the M13mp8 or mp10 vector (see Fig. 3). For introduction into yeast cells, YlpLEU2 
containing SUP 53 or a mutant derivative was linearized with A val and San. The small A val-San fragment contained both the tRNA gene and 
the LEU2 marker. 
respectively. Molecular cloning procedures were those de-
scribed by Maniatis et al. (32). 
By using the unique intragenic Alul site of SUP53~IVS 
(Fig. lB and 2C), the Alu~3 mutant (Fig. 3) was con-
structed by cloning complementary oligonucleotides. The 
5' -hydroxyl oligonucleotides were mixed in equimolar 
amounts and annealed in 6 mM Tris chloride (pH 7.9}-50 
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FIG. 3. Sequences of SUP53 intron mutants. The sequences of 
the various SUP53 intron mutants examined are shown. Their 
construction is described in detail in Materials and Methods. Arrows 
indicate the position of the SUP53 32-bp intron. Underlined se-
quences indicate the anticodon (CTA), the intron sequence comple-
mentary to the anticodon (TCTTGA), and the unique, intronic Hpal 
restriction enzyme site (GTT AAC). The small arrow indicates the 
site of the Hpal enzyme cut. Lowercase letters show the base 
changes introduced by oligonucleotide-directed mutagenesis. 
Overlined sequences point out the unique, intragenic Alul (AGCT) 
and Stul (AGGCCT) restriction enzyme sites created in the 4IVS 
and INS mutants, respectively. 
mM NaCl--6 mM MgCl2 by heating to 80°C followed by slow 
cooling to room temperature. As described above, half-
tRNA genes were isolated from SUP53~IVS DNA. These 
restriction fragments and annealed oligonucleotides were 
ligated into Ml3mpl0 linearized with EcoRI and BamHI. 
Positive plaques were identified as previously described (39). 
Synthetic oligonucleotides were kindly provided by B. 
Kaplan (City of Hope, Duarte, Calif.) and S. Horvath, Carol 
Graham, and M. Tomich (California Institute of Technol-
ogy). All oligonucleotides were purified on 20% acryl-
amide-7 M urea gels. The sequence of all SUP53 mutant 
genes was confirmed by DNA sequencing by the method of 
Sanger et al. (50) with a SUP53-specific oligonucleotide 
primer. Replicative-form DNA was prepared by the alkaline 
lysis method (3). 
In vitro transcription. A yeast nuclear extract preparation 
(YNE) (9) was used to transcribe in vitro S UP53 and 
derivative mutant genes. This extract contains the enzyme 
activities to synthesize the primary transcript of a tRNA 
gene; to end-process this transcript, generating mature 5' 
and 3' ends; to effect specific base modifications in the 
presence of appropriate cofactors; and to add the 3'-terminal 
CCA nucleotides. 
Transcription reactions were carried out essentially by the 
method of Newman et al. (39). The precise amounts of YNE 
and template used in each reaction were optimized by 
titration of the given YNE preparation. To study base 
methylations effected by activities present in YNE, the 
methyl donor S-adenosyl-L-methionine (SAM; p-tolu-
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FIG. 4. In vitro transcription of SUP53 and mutants. The [a-
32P]UTP-Iabeled products of SUP53 and mutant DNAs transcribed 
in vitro are shown. All transcription templates were replicative-form 
DNA of the tRNA gene cloned in a M13 vector. Panels A and B 
represent different transcriptional mixes with the same YNE prep-
aration. The larger band in each track represents the primary 
transcript of each gene, containing -10 nucleotides of 5' and -5 
nucleotides of 3' extension plus the mature domain (and IVS). The 
smaller dominant band(s) is the end-processed transcript from which 
these extensions have been removed and 3'-terrninal CCA added 
posttranscriptionally. This secondary transcript is unspliced. Prod-
ucts were resolved on 8% polyacrylamide-8 M urea thin gels. 
Autoradiography was done as described in Materials and Methods. 
enesulfonic acid salt, Sigma Chemical Co., St. Louis, Mo.) 
was added to the transcription cocktail (0.02 mM) (6) . The 
reaction mixes were incubated at 30°C for 15 min and 
processed as described previously (39). RNA products were 
resolved on 8% acrylamide-7 M urea or 10% acrylamide-4 
M urea gels . After visualization by autoradiography on 
Kodak XAR5 film (Eastman Kodak, Rochester, N.Y.) with 
Cronex Lightning-Plus intensifying screens (E. I. du Pont de 
Nemours, Inc., Wilmington, Del.), RNAs were passively 
eluted. Eluted RNAs were ethanol precipitated with the 
appropriate carrier (20 JJ.g oftRNA or glycogen per ml) prior 
to nucleotide analysis or in vitro splicing assays. 
RNA analysis. Separation of modified nucleosides was 
done by the method of Saneyoshi et al. (49) as previously 
described (22). Since the in vitro-synthesized RNA was 
radiolabeled with a single ribonucleoside triphosphate, the 
base modifications at given positions could be investigated 
by digestion with different RNases. RNases Tt. T2 , and A 
(pancreatic) produce nucleoside-3' -monophosphates, and 
the labeled phosphate is derived from a nearest-neighbor 
transfer, whereas nuclease Pl produces nucleoside-5'c 
monophosphates, and the labeled phosphate remains with its 
input nucleotide. All RNases were obtained from Cal-
biochem, La Jolla, Calif., and used as previously described 
(22). 
In vitro splicing assays. To investigate the suitability of 
SUP53 mutants as substrates for S. cerevisiae tRNA 
endonucleases and ligase, in vitro-transcribed RNAs were 
used in cutting and ligation assays (15, 16, 45a). Equal 
amounts of radioactivity of each RNA precursor were used 
in comparable cutting or cutting-ligation assays. These 
RNAs were derived from a single transcription reaction 
MoL CELL. BtoL. 
cocktail and were assumed to have similiar radioisotopic 
specific activity. 
Partially purified yeast endonuclease (fraction VI; DEAE 
fractions 26 through 29; approximately 800-fold purified; 
kindly provided by C. Peebles [45]) and yeast ligase (fraction 
IV, heptyl-agarose pool; approximately 300- to 400-fold 
purified; kindly provided by C. Greer and E. Phizicky [16, 
45a]) were used at dilutions which had been determined to 
give 50% cutting of the SUP53 precursor by endonuclease (1 
JLI of a 1:30 dilution per 10-JJ.l reaction mixture) and virtually 
100% ligation of the resultant half-molecules by ligase (2 JJ.l 
of a 1:50 dilution per 10-JJ.l reaction mixture) in 20 min at 
30°C. Mter incubation the reaction mixes were processed as 
described previously (39). Products were resolved on 10% 
acrylamide-4 M urea gels. 
The identity of RNA products was based on their size and 
their appearance and disappearance under appropriate con-
ditions . In several cases, their identity was confirmed by 
two-dimensional separation of RNase T1 oligonucleotides 
(data not shown). 
Yeast transformation. SUP53 and mutant derivatives 
cloned in the yeast integration plasmid YlpLEU2 were 
introduced into S . cerevisiae SL183-21C by the method of 
Ito et at. (19). Because of the close linkage between the 
SUP53 locus and the LEU2 marker (1, 10, 31), cells trans-
formed with YlpLEU2SUP53 or mutant derivative DNAs 
linearized with A val and Sail (Fig. 2A) can integrate both the 
SUP53 and LEU2 genes by homologous recombination (47). 
Transformants were initially screened for acquisition of a 
Leu+ phenotype after growth for 3 to 4 days at 30°C. 
Suppression testing. To assay the presence and function of 
SUP53 and mutant derivatives, Leu+ transformants were 
tested for their ability to grow on synthetic yeast medium 
minus tryptophan by the method of Shaw and Olson (52). Of 
the six amber-suppressible nonsense mutations in 
SL183-21C, the trpi-I(Am) marker was found to clearly 
discriminate the suppressor strength of the tRNA encoded 
by the SUP53 allele (data not shown). Briefly, individual 
Leu+ transformants were grown overnight in YPD medium 
and then washed and suspended in water to 1 ODw/ml (-2 
x 107 cells per ml). Serial dilutions (106 to 103 cells per ml) 
were made in water. A 5-JJ.I amount of each dilution (lOS to 
101 cells) was spotted on tryptophan drop-out plates. Plates 
were scored for growth after 3 to 4 days at 30°C. Twenty to 
30 Leu+ transformants from two independent yeast transfor-
mations with each tRNA gene were assayed for suppressor 
function. In each group of Leu+ transformants, at most 20% 
of the transformants showed no growth in the absence of 
tryptophan, indicating that the suppressor tRNA gene prob-
ably was not introduced by the transplacement event. Quan-
tification of suppressor function was based only on the Leu+ 
transformants which grew on tryptophan drop-out plates. 
The parent strain, SL183-21C, exhibited no growth in the 
absence of tryptophan. 
RESULTS 
Mutant construction. Figure 3 shows the sequences of the 
SUP53 intron mutations. The ACBP mutant contained three 
base changes which interrupted the conserved base-pairing 
in the precursor tRNA between an intron sequence and the 
anticodon (43). The INS mutant had a 2-base "intron" 
introduced. Four mutant genes contained total or partial 
deletions of intron sequences (AIVS, A3'1VS, A5'IVS, and 
Alu5-+3) . 
The AIVS mutant contained a total deletion of the 32-base 
intron. As such, tRNA.1tvs had the same sequence and, 
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FIG. 5. Modified-nucleotide analysis of SUP53 and mutant transcripts made in vitro in the presence of [a-32P]UTP and SAM. 
End-processed tRNAs were recovered from the transcription gel as described in Materials and Methods. Labeled RNA , in the presence of 
20 IJ.g of carrier tRNA, was digested with RNase T2, RNase T., and RNase A. Nucleoside-3'-monophosphates, labeled by nearest-neighbor 
transfer from [a-32P]UTP, were resolved as described in Materials and Methods. (A and B) Chromatograms of SUP53 and mutant RNAs. 
Arrows indicate modified nucleotides . The tRNAs in panel A are the products of a single transcription cocktail. The tRNA in panel B 
represents an independent transcription with the same YNE preparation. (C) Cartoon identifying the nucleotide-3'-monophosphates. A single 
dinucleotide (2'-0-Me-GpGp) was seen. The presence of the methyl group on the 2'-hydroxyl rendered this linkage insensitive to the 
nucleases used. Arrows indicate the direction of chromatography. See the legend to Fig. 1 for abbreviations. 
presumably, structure as mature tRNAsuP53 • .:15'IVS pre-
tRNA had a deletion of the first 19 bases of the intron. The 
Alu5-3 mutant encoded a 15-base intron which retained the 
normal sequence at intron-exon boundaries and the con-
served complementarity between the intron and the 
anticodon . .:13'1VS contained a 19-base intron with altered 
sequence at the 3' intron-exon junction, while retaining the 
SUP53 sequence at the 5' splice junction. 
Transcription of SUP53 intron mutants. The SUP53 and 
intron-mutated genes were transcribed in vitro by using 
YNE (9). This extract contains the activities required to 
transcribe tRNA genes (polymerase III and associated fac-
tors), end-process the primary transcript, posttranscription-
ally add the 3'-terminal CCA, and introduce base modifica-
tions (in the presence of appropriate cofactors) . While this 
extract contains the activities needed to remove introns and 
ligate tRNA exons, splicing proceeds inefficiently under the 
salt conditions optimal for transcription. Splicing of the 
pre-tRNAs was examined with partially purified tRNA-
splicing enzymes (see Fig. 8). 
Figure 4 shows the transcription products of each mutant 
gene made in the presence of [a-32P]UTP. The largest 
band(s) was the primary gene transcript, whereas the smaller 
band(s) contained the RNA from which the -10 nucleotides 
of 5' and -5 nucleotides of 3' extensions have been re-
moved. The small RNA(s) had at least partial terminal 
addition of CCA. 
All mutants were transcribed efficiently. Also, except for 
MVS and .:13'IVS, the primary transcripts were efficiently 
end-processed (Fig. 4) (D. Engelke, personal communica-
tion). In several tracks, faint band(s) comigrated by size with 
end-processed .:1IVS RNA(s) . These bands probably repre-
sent the products of splicing. 
Analysis of the anticodon wobble base modification. Based 
on the previous observation that deletion of the IYS from the 
SUP6 gene resulted in no modification of an anticodon 
nucleotide, attention was focused on potential modifications 
of the wobble base cytosine (C34) in the SUP53 CUA 
anticodon. This nucleotide is known to be a 5-methyl-
cytosine in tRNA~eu in vivo (Fig. 18) (23, 55). 
The SUP53 and mutant DNAs were transcribed in the 
presence of [a-32P]UTP and the methyl donor SAM. Mature 
SUP53 RNA contained two 5-methylcytosine modifications 
(C34 and C48) (Fig. 18). However, transcripts labeled with 
[a-32P]UTP and digested with RNases which effect nearest-
neighbor transfer of the a-position phosphate labeled only 
the potentially modified wobble base cytosine (C34). 
End-processed RNAs were excised from the transcription 
gel and digested with RNases T1o T2, and A. Nucleosides 
were resolved in a two-dimensional chromatographic system 
that separates modified nucleosides from their unmodified 
counterparts (22, 49). The autoradiograms of the products 
derived from pre-tRNAsuP53 and mutant RNAs is shown in 
Fig.· 5. Only the SUP53 RNA contained the expected 5-
methylcytosine modification. None of the six mutants had 
any detectable cytosine modifications. Except for the .:1IVS 
mutant, they showed only limited amounts of ribothymidine, 
derived from modification of U54 to T54 (Fig. 1). The limited 
2668 STROBEL AND ABELSON 
A 
• 
• 
• 
B 
Ori 
SUP 53 
t.JVS 
• 
Ap 
~Cp 
0 ........ .,0 
Gp ·· ...... .: Up 
1/rp 
2-----
ACBP 
INSERT 
FIG. 6. Modified-nucleotide analysis of SUP53 and mutant tran-
scripts made in vitro in the presence of [a-32P]CTP and SAM. 
End-processed tRNAs, made in vitro in the presence of 10 ILCi of 
[a-32P)CTP and 0.02 mM SAM, were digested and chromatographed 
as described in Materials and Methods. (A) Chromatograms of 
SUP53 and mutant RNAs . A single modified nucleotide-3'-
monophosphate (pseudouridine [I!Jp)) was found in all digests. All 
tRNAs are the products of a single transcription cocktail. (B) 
Cartoon identifying the nucleotide-3'-monophosphates. Arrows in-
dicate the direction of chromatography. See the legend to Fig. 1 for 
other abbreviations . 
amount of ribothymidine presumably reflects inefficient U-
to-T modification in this system. 
In addition to T54, the .:liVS mutant RNA contained two 
other modified nucleotides not seen in the SUP53 precursor: 
2'-0-methyi-G and pseudouridine (1)1), presumably repre-
senting positions 18 and 32, respectively (Fig. 1). The 
2' -0-methylation of the ribose sugar is a modification found 
only in mature tRNAs (17, 48). In contrast, the INS mutant, 
which differed from MVS only by the inclusion of a 2-base 
intron (or 2-base insertion in the mature tRNA anticodon 
loop) did not exhibit either modification. Therefore, .:liVS is 
apparently being recognized as a mature tRNA, while the 
INS mutant RNA is not. 
Comparison of base modifications made in two precursor 
and two mature tRNAs. Any alteration in the structure of 
SVP53-derived precursor tRNA resulted in a lack of the 
expected anticodon modification. Furthermore, insertion of 
2 bases into the anticodon loop severely altered the detected 
modification pattern of a "mature" tRNA. Therefore, these 
mutants provide a means of investigating the substrate 
requirements of the enzymes which effect other base modi-
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L>.IVS INSERT 
• 
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• Ori 
2-----
FIG. 7. Modified-nucleotide analysis of SUP53 and mutant tran-
scripts made in vitro in the presence of [a-32P]GTP and SAM. 
End-processed tRNAs were recovered from the gel as described in 
Materials and Methods. Labeled RNA, in the presence of 20 ILg of 
carrier tRNA, was digested with nuclease Pl. The resulting nucle-
otide-5'-monophosphates were resolved as described in Materials 
and Methods. (A) Chromatograms of SUP53 and mutant RNAs. 
Since nuclease P1 yields nucleotide-5'-monophosphates, the a-32P 
label remains with the input nucleotide. SUP53, ACBP, and INS 
mutant RNAs showed only a single modified nucleotide-5'-
monophosphate (p-2,2-dimethyl-G). All tRNAs were the products of 
a single transcription cocktail. (B) Cartoon identifying the 
unmodified and modified 5'-GMPs. Arrows indicate the direction of 
chromatography. See the legend to Fig. 1 for abbreviations. 
fications in SVP53 RNA. The SUP53, ACBP, .:liVS, and 
INS RNAs were examined for additional nucleoside modifi-
cations. 
SVP53 and the three derivatives were transcribed in vitro 
in the presence of either [a-32P]CTP or [a-32P]GTP. The 
[32P]CTP-Iabeled, end-processed RNAs were cleaved with 
RNases which effect nearest-neighbor transfer ofthe labeled 
phosphate (Fig. 6). The [a-32P]GTP-labeled RNAs were 
digested with nuclease P1, generating 5 '-monophosphates 
and leaving the a-phosphate with the input nucleoside (Fig. 
7). The only potentially modified bases which were not 
investigated were C12 (4-acetyi-C) and U19,21 (dihydro-
uridine) (Fig. 1). 
Figure 6 shows the nucleotides labeled by nearest-
neighbor transfer from [a-32P]CTP. All four RNAs contained 
pseudouridine as the sole detectable modified nucleotide, 
representing the expected U to 1)1 modifications at positions 
39 and 55 (Fig. 1). Precise modification at each position 
could not be discriminated. Expected modifications of 0 10 
and 0 27 (Fig. 1) could not be seen by this strategy since these 
modified nucleotides comigrated with Cp and Ap. 
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TABLE 1. Base modification of SUP53 and mutants in vitroa 
Modified base• 
2-Methyi-G (10) 
2'-0-Methyi-G (18) 
2,2-Dimethyl-G (27) 
ljJ (32) 
5-Methyi-C (34) 
1-Methyi-G (37) 
ljJ (39, 55) 
5-Methyi-C (48) 
Ribothymidine (54) 
SUP53 
+ 
+ 
+ 
+ 
ACBP 
+ 
+ 
+ 
4IVS 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
INS 
+ 
+ 
+ 
• Compilation of data shown in Fig. 5 through 7. In all cases, the data 
represent the results of several independent chromatographic separations with 
tRNAs derived from independent transcriptions. In some cases, the identity 
of spots was confirmed by examining their mobility in different chromato-
graphic systems with different labeling and digestion strategies (data not 
shown). Under the general experimental protocol, modification of the pseu-
douridines (o!J) at positions 39 and 55 could not be discriminated. All base 
modifications present in mature tRNA suPSJ (tRNA~") were examined except 
the 4-acetyi-C modification at position 13 and the dihydrouridine modifica-
tions at positions 19 and 21 (see Fig. 1). 
• Numbers in parentheses indicate the position of the modified residue in 
mature tRNA suPSJ, with the numbering convention established for yeast 
tRNAPI>c (see Fig. 1). 
Modified guanosine residues in SUP53 and the three 
mutants are shown in Fig. 7. All four RNAs contained 
2,2-dimethylguanosine (027 , Fig. 1). Only the .:liVS mutant 
containedothermodified G residues: 2-methyl-G, 2' -0-methyl-
G, and 1-methyl-G (Fig. 1). 
The expected modification of C48 to 5-methylcytosine 
(Fig. 1) was also examined (data not shown). This modifica-
tion could not be clearly detected in any of the four RNAs 
examined. Previously, this modification was shown to be 
present in the tRNAreu precursor in vivo (23). Presumably, 
the inability to detect this modification is due to the in vitro 
system used. 
Table 1 summarizes the chromatographic data of Fig. 5 
through 7. Of the five examined modifications known to 
occur in pre-tRNAreu (23, 55), the ACBP mutant differed 
only in the absence of the anticodon 5-methylcytosine. The 
INS mutant, an altered mature tRNA, was obviously 
undermodified compared with .:liVS. 
In vitro splicing of pre-tRNAsuPsJ and derivative mutant 
pre-tRNAs. To investigate which, if any, intron features 
were critical for the splicing of a pre-tRNA, SUP53 and 
derivative mutants were tested for their ability to serve as 
substrates for the S. cerevisiae tRNA endonuclease and 
ligase. SUP53 and mutant genes were transcribed in vitro in 
the presence of [a-32P]UTP and SAM. End-processed pre-
cursors were excised from the transcription gel and assayed 
with partially purified S. cerevisiae tRNA splicing enzymes 
(Fig. 8A and B). All tracks contained equal counts of 
precursor derived from a single transcription cocktail. Each 
pre-tRNA was assayed with endonuclease alone and endo-
nuclease plus ligase. Both reactions were carried out in the 
presence of ATP and Mg2+ (ligation conditions). 
The SUP53, ACBP, .:l5'IVS, and Alu~3 RNAs were cut, 
as evidenced by the production of3' and 5' half-molecules in 
SUP53 ACBP t.3,1VS t.5,1VS INS t.IVS 
++++ +++ +++ ++ ENDO 
LIGASE 
SUP53 Alu5-3 
- + + + + 
+ - + 
- - + - + 
+ tRNA + 
+ 5' Half + 
---
+ IVS + 
8 
FIG. 8. In vitro splicing of SUP53 and intron mutant pre-tRNAs. Partially purified yeast tRNA endonuclease and tRNA ligase were used 
in splicing assays in the presence of 2 mM ATP as described in Materials and Methods. In vitro-synthesized, end-processed pre-tRNAs 
labeled with [a-32P)UTP were recovered from a 10% polyacrylamide-4 M urea gel as described in Materials and Methods and were 
precipitated with 20 ILg of carrier glycogen. Since each panel represents the RNA derived from a single transcription cocktail, the specific 
activity of the RNAs were assumed to be virtually equal. Thus, equal Cerenkov counts of each pre-tRNA were used in each cutting or splicing 
reaction mixture. Reaction products were resolved on 10% polyacrylamide-4 M urea-TBE thin gels. 
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TABLE 2. Suppressor function of SUP53 and intron mutantsa 
tRNA 5-Methylcytosine Splicing Suppression6 
modification 
SUP53 Yes Yes +++++ 
ACBP No Yes +++ 
Alu5-+3 No Yes +++ 
~5'IVS No Yes +++ 
~3'IVS No No (some cutting at 
5' junction) 
~IVS No _c +++ 
INS No No 
• Suppressor function was quantified as described in Materials and Meth-
ods. S. cerevisiae SL183-21C was transformed with a linear restriction 
fragment containing both the tRNA gene and the LEU2 marker (see Fig. 2). 
Leu+ transformants were initially selected and tested for their ability to 
suppress the trpl-l(Am) marker as described in Materials and Methods. The 
quantification of suppressor fuction for SUP53 or mutants was based only on 
the transformants which grew in the absence of tryptophan, reflecting 
acquisition of the suppressor tRNA gene by transplacement. 
6 Strong suppressor ( + + + + + ), Growth at low cell density (101 cells); 
weaker suppressor ( + + + ), growth only at higher cell density (103 cells); null 
suppressor (-), no growth even at the highest cell density (10" cells). SL183-
21C exhibited no growth in the absence of tryptophan at any cell density. 
c -, ~IVS contains no intron. 
the presence of endonuclease. Furthermore, these half-
molecules were converted to mature-size tRNA with the 
addition of ligase. The diVS and INS RNAs were not 
recognized by the splicing endonuclease as appropriate 
precursor tRNAs: neither mutant produced any detectable 3' 
or 5' half-tRNA molecules. 
The most startling result was seen with pre-tRNA~3'tvs. 
The mutant RNA produced neither detectable mature tRNA 
nor 3' half-molecules. Rather, in the presence of endonucle-
ase or endonuclease plus ligase, a species which comigrated 
by size with 5' half-molecules was generated. Additionally, a 
family of new bands was observed which migrated in a 
position consistent by size with "two-thirds" molecules. By 
inference, these molecules would contain all or part of the 
IVS and the 3'-half of the precursor. 
Suppressor function of SUPSJ and intron mutants in vivo. 
The observed in vitro base modifications and splicing behav-
ior of these mutants were correlated with their ability to 
suppress a nonsense mutation in vivo. S. cerevisiae 
SL183-21C was transformed with DNA containing the 
SUP53 or mutant allele and the LEU2 marker on a single 
restriction fragment (Fig. 2). Transformants were initially 
selected for acquisition of the LEU2 marker. The Leu+ 
transformants were secondarily tested for their ability to 
suppress the trpl-l(Am) marker by growth on minimal 
medium minus tryptophan. Cells were spotted on tryptophan 
drop-out plates at different cell densities. Suppressor func-
tion was quantified by the lowest cell density at which 
growth was observed. At all cell densities tested, no growth 
was seen with the parent SL183-21C cells (Table 2). 
Cells receiving the intact SUP53 gene grew in the absence 
of tryptophan at all densities tested (as few as 10 cells 
plated), indicating efficient suppression of the amber muta-
tion. Four mutants (ACBP, d5'IVS, Alu5--+3, and .:1IVS) 
grew only at significantly higher cell densities (1,000 cells), 
indicating inefficient suppression of the amber mutation. 
These four mutants all lacked the wobble base 5-methyl-
cytosine modification found in SUP53 in vitro. The two 
intron-containing mutants whose precursors could not be 
spliced (d3'IVS and INS) were null suppressors. Therefore, 
the nonsplicing phenotype in vitro faithfully correlated with 
disfunction in vivo. 
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DISCUSSION 
These data confirm that deletion of a tRNA gene IVS 
results in an altered mature tRNA product (22). Further-
more, they emphasize that any change which perturbs the 
intron and, in tum, the pre-tRNA is sufficient to render the 
mature tRNAsuPsJ less efficient in its translational function 
(as assayed by amber suppressor efficiency). Finally, they 
indicate that the reduced suppressor function is correlated 
with undermodification of the 5-methylcytosine in the wob-
ble base position of the anticodon. 
The suppression of a nonsense codon is critically affected 
by both the nature ofthe suppressor tRNA anticodon region 
and the codon context in the mRNA being translated (37). 
Since these mutants were assayed with a single nonsense 
codon [trpl-l(Am) mutation], these different levels of sup-
pression are considered to reflect the anticodon modifica-
tion. The 5-methylcytosine modification is apparently nec-
essary for optimal anticodon-codon pairing. A number of 
studies have shown that a base change in or undermodifica-
tion of the wobble base severely alters the translational 
efficiency of a tRNA (8, 58; T. G. Hagervall, Ph.D. thesis, 
University of Umea, Umea, Sweden, 1984). Modifications 
can both restrict and increase the wobble base pairing 
capacity (38, 54). 
As noted in the Results section, the C48 modification 
(normally a 5-methyl-C; Fig. 1) was not clearly detected in 
any RNA in vitro. However, lack of the modification at this 
position is unlikely to have a direct effect on anticodon-
codon interactions. There is only one clear example of a 
suppressor tRNA whose functionality is correlated with a 
change not in the anticodon or anticodon stem-loop region: 
the E. coli tRNA Trp UGA suppressor arises by a single base 
change in the D stem (18). 
Since base modifications have not been found to be critical 
to the secondary or tertiary structure of a tRNA (25), the 
down-suppressor phenotype of these mutants is probably 
due to the absence of wobble base modification. Inherent in 
this interpretation is the assumption that the altered pre-
tRNAs, which are end-processed and spliced in vitro, are 
appropriately processed beyond the precursor stage, includ-
ing the addition of base modifications, and produce stable 
cytoplasmic tRNAs in vivo. Critical to this point would be 
undermodification of the hypermodified base position (1 base 
3' of the anticodon). The hypermodification of this base has 
been implicated as critical to codon-anticodon interaction (4, 
12) and its undermodification results in an antisuppressor 
phenotype (20, 29). However, all of the functional mutants 
showed the same level of suppression as the diVS mutant, 
which contained the appropriate modification of this position 
(Fig. 7). 
Nucleotide modifications are added on a specific tRNA 
processing intermediate (35, 41). The data presented here 
illustrate that the enzymes which modify tRNAsuPsJ fall into 
three classes: those which are insensitive to the presence or 
absence of an IVS; those which are dependent on precursor 
structure (including the presence of an intact IVS); and those 
which recognize only the mature tRNA species (lacking an 
IVS). 
The modifications made regardless of the presence or 
nature of an IVS are among those which are highly con-
served in eucaryotic tRNAs (2,2-dimethyl-027 , T54 , and 
lf!39•55). The enzymes which effect these modifications must 
be recognizing the cloverleaf structure maintained in the 
presence and absence of an IVS. As noted by McClain and 
Seidman (34), this constancy of the cloverleaf structure 
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eliminates the need for a multiplicity of enzymes for different 
tRNAs. Furthermore, mutants which disturb conserved 
structure would not be recognized as appropriate substrates, 
preventing the production of deleterious RNAs. 
The two expected 5-methylcytosine modifications exem-
plify activities which are apparently sensitive to the struc-
ture of the precursor tRNA. The anticodon modification was 
only found in the intact precursor. Previous studies have 
shown that the rather conserved 5-methylation of C48 was 
introduced on unspliced pre-tRNAs (23, 41). However, the 
12 yeast tRNAs which contained this position 48 cytosine 
modification included both IVS- and non-IVS-containing 
species (55). This suggests either that a single methylase, 
insensitive to the presence of an intron, effects this modifi-
cation or that multiple methyltransferases are involved. 
Our inability to detect methylation of C48 in vitro strength-
ens the evidence for multiple enzymes which effect the same 
modification in a single tRNA. Similar results were seen by 
Keith et al. (24) with a partially purified 5-methyl-C synthase 
from HeLa cells. Using yeast and E. coli tRNAPhe as 
substrates, they found that this enzyme methylated C48 and 
C49 in both RNAs. However, an expected 5-methylation of a 
cytosine in the anticodon stem was not made. They noted 
that the methylated cytosines lay in a similar primary se-
quence, indicating that the methyltransferases that modify 
tRNAs may have very specific substrate recognition, includ-
ing primary RNA sequence. 
The final class of modifications found in tRNAsuP53 were 
those found only in mature tRNA, as exemplified by .:1IVS 
RNA. Since these modifications were made on a mature 
tRNA independent of its production by splicing, these two 
tRNA maturation steps must not be linked obligatorily in the 
production of an intron-containing tRNA. The ribose 
methylation of G18 and the !-methylation of G37 
(hypermodified base position) are well documented as being 
dependent on mature structures (17, 41, 48). Furthermore, 
\fl32 was found only in .:1IVS RNA, in contrast to the presence 
of other pseudouridylations (\fl32,55) in all RNAs examined. 
Multiple pseudouridine synthases have been documented in 
other systems (13, 22). Finally, the relatively conserved 
2-methyl-G10 was detected only in mature tRNAsuP53• In 
Xenopus laevis oocytes, Nishikura and DeRobertis (41) 
found that 2-methyl-G was made on pre-tRNATY•. Whether 
this is another example of multiple enzyme activities or 
reflects the difference in analyzing the modification pattern 
in a homologous rather than heterologous system is un-
clear. 
These data clearly illustrate that significant changes can be 
made in an intron without affecting the absolute ability of the 
precursor to be spliced. Johnson et al. (21) and Raymond and 
Johnson (46) showed that several small insertions into and 
deletions of the yeast tRNA!""u intron did not impair tran-
scription, end-processing, and splicing in yeast extract or X. 
laevis oocytes. The efficiency of splicing decreased with 
increased size of the insertion, and RNAs with large inser-
tions were neither end-processed nor spliced, suggesting that 
larger changes are significantly perturbing the overall struc-
ture of the precursor RNA. In contrast, the smaller inser-
tions and deletions apparently preserved the basic intron 
and, more importantly, the precursor structure. 
Of the SUP53 intron mutants examined here, only one 
(.:13'IVS) was refractory to the splicing enzymes. This mu-
tant precursor RNA was poorly recognized by other tRNA 
maturation enzymes whose activities remove 5' and 3' 
extensions from the primary transcript. By analogy to other 
mutants (2, 26-28, 33, 42, 44, 59), this pre-tRNA must not 
conform to an appropriate precursor secondary or tertiary 
structure. 
A computer-generated secondary structure for .:13'IVS 
RNA suggests that this precursor does not form aD stem or 
loop, but an intron sequence can base-pair to D stem-loop 
nucleotides. Numerous studies have shown that alteration of 
D stem-loop sequence or structure affects end-processing 
and splicing of precursor tRNAs (2, 27, 33, 39, 44). Addi-
tional changes in the .:13'IVS intron sequence which dis-
rupted the capacity to form this aberrant secondary structure 
partially rescued the nonprocessed, nonspliced phenotype 
(data not shown). 
The results of nuclease sensitivity (30) and chemical 
modification (57) studies of RNA structure are consistent 
with the existence of base-pairing between the anticodon and 
a complementary intron sequence in S. cerevisiae pre-
tRNAs. As noted by Ogden et al. (43), such secondary 
structure is not necessarily found in pre-tRNAs from other 
organisms. Several intron-containing precursors from 
Schizosaccharomyces pombe which do not exhibit this com-
plementarity are inefficiently spliced in S. cerevisiae extracts 
(11, 56). Therefore, since this structure is invariant among 
the nineS. cerevisiae precursors (30, 43, 57), it was assumed 
to be important for recognition by the homologous splicing 
machinery. However, the ACBP and .:15'IVS mutants, which 
have a disruption and a deletion, respectively, of the com-
plementary region, were cut and ligated by the yeast tRNA 
endonuclease and ligase (Fig. 8). Thus, there is no absolute 
requirement for this particular secondary structure for rec-
ognition by the enzymes. 
Neither the .:1IVS nor the INS mutant RNAs were spliced. 
These results are not surprising since mature tRNAs are not 
substrates for, and in fact appear to inhibit, endonuclease 
activity (P. Green and J. Abelson, unpublished observation). 
Clearly, the insertion of a 2-base intron, as exemplified by 
the INS mutant, was insufficient to define this RNA as a 
precursor. The smallest intron known to be excised (ineffi-
ciently) by S. cerevisiae enzymes is 8 nucleotides long (S. 
pombe pre-tRNALys [11]). Further studies must be done to 
elucidate the lower limit of size or structure sufficient for 
endonuclease recognition. 
The tRNA ligase protein has been purified, its gene cloned 
(45a), and its mechanism of action defined (16, 45a). How-
ever, the integral-membrane-bound endonuclease has defied 
complete purification (45; P. Green and J. Abelson, unpub-
lished observation). Until the highly purified enzyme is 
available, the precise interaction between endonuclease and 
its precursor tRNA substrate cannot be elucidated. How-
ever, the .:13'IVS mutant RNA, which was refractory to 
complete cleavage by endonuclease did exhibit inefficient, 
partial cleavage. This mutant RNA generated some 5' half-
molecules and presumptive two-thirds molecules (IVS plus 
3' -half; see Fig. 8). Since the 5' splice junction lay in a 
constant position in all of the precursors, it is tempting to 
speculate that this junction is more easily recognized and cut 
by endonuclease than the 3' junction. 
Finally, none of the mutant precursor tRNAs contained 
the full complement of base modifications found in the 
SUP53 precursor (Table 1), yet most of these precursors 
were successfully spliced. These data suggest that base 
modifications, which play no defined role in maintenance of 
tRNA structure, are not required for splicing to occur. 
Recently, the yeast pre-tRNAPhe has been synthesized 
in vitro from a T7 bacteriophage promoter by the cognate 
RNA polymerase. This totally unmodified precursor tRNA 
is efficiently cut and ligated by the S. cerevisiae en-
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zymes in vitro (V. Reyes and J. Abelson, unpublished 
observation). 
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